Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: DarioHealth Corp., 3 years.
DarioHealth Corp.
Director
Lucid Diagnostics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 23, 2026 | DarioHealth Corp. | Open-market purchase | +14,430 | $6.93 | $100,000 |
| May 20, 2026 | Lucid Diagnostics Inc. | Open-market purchase | +245,000 | $1.00 | $245,000 |
| Feb 20, 2026 | Lucid Diagnostics Inc. | Grant or award | +123,000 | — | — |
| Sep 11, 2025 | DarioHealth Corp. | Grant or award | +20,000 | — | — |
| Aug 20, 2025 | Lucid Diagnostics Inc. | Open-market purchase | +100,000 | $1.02 | $102,000 |
| May 22, 2025 | Lucid Diagnostics Inc. | Open-market purchase | +33,218 | $1.32 | $43,848 |
| May 21, 2025 | Lucid Diagnostics Inc. | Open-market purchase | +129,684 | $1.32 | $171,183 |
| May 20, 2025 | Lucid Diagnostics Inc. | Open-market purchase | +187,098 | $1.30 | $243,227 |
| Feb 20, 2025 | Lucid Diagnostics Inc. | Grant or award | +112,800 | — | — |
| Aug 12, 2024 | DarioHealth Corp. | Derivative conversion | +965 | $19.10 | $18,432 |
| Mar 6, 2024 | DarioHealth Corp. | Grant or award | +70,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.